<?xml version='1.0' encoding='UTF-8'?><batch xmlns="http://www.quertle.com/schema/UFT" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.quertle.com/schema/UFT uft.xsd" schemaVersion="1.1"><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20180917_0</doc-id></doc-ids><date-published><year>2018</year><month>09</month><day>17</day></date-published><authors><author><last-name>Sagonowsky</last-name><first-name>Eric</first-name></author></authors><title>Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO </title></doc-meta><content><body><section><text>The race is on for a next-generation pneumococcal vaccine. Merck has already pushed its 15-valent candidate into phase 3, and on Thursday, Pfizer CFO Frank D’Amelio said his company is “all in” on reaching the market as soon as possible with its candidate. 
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/pfizer-all-advancing-next-gen-pneumococcal-vaccine-candidate-cfo</ext-link></ext-links></extra></doc><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20180917_0</doc-id></doc-ids><date-published><year>2018</year><month>09</month><day>17</day></date-published><authors><author><last-name>Sagonowsky</last-name><first-name>Eric</first-name></author></authors><title>Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO </title></doc-meta><content><body><section><text>The race is on for a next-generation pneumococcal vaccine. Merck has already pushed its 15-valent candidate into phase 3, and on Thursday, Pfizer CFO Frank D’Amelio said his company is “all in” on reaching the market as soon as possible with its candidate. 
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/pfizer-all-advancing-next-gen-pneumococcal-vaccine-candidate-cfo</ext-link></ext-links></extra></doc><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20180917_0</doc-id></doc-ids><date-published><year>2018</year><month>09</month><day>17</day></date-published><authors><author><last-name>Sagonowsky</last-name><first-name>Eric</first-name></author></authors><title>Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO </title></doc-meta><content><body><section><text>The race is on for a next-generation pneumococcal vaccine. Merck has already pushed its 15-valent candidate into phase 3, and on Thursday, Pfizer CFO Frank D’Amelio said his company is “all in” on reaching the market as soon as possible with its candidate. 
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/pfizer-all-advancing-next-gen-pneumococcal-vaccine-candidate-cfo</ext-link></ext-links></extra></doc></batch>